Skip to main content
Top
Published in: Orphanet Journal of Rare Diseases 1/2019

Open Access 01-12-2019 | Research

Information needs of physicians regarding the diagnosis of rare diseases: a questionnaire-based study in Belgium

Authors: Liese Vandeborne, Eline van Overbeeke, Marc Dooms, Birgit De Beleyr, Isabelle Huys

Published in: Orphanet Journal of Rare Diseases | Issue 1/2019

Login to get access

Abstract

Background

Late and misdiagnoses of rare disease patients are common and often result in medical, physical and mental burden for the patient, and financial and emotional burden for the patient’s family. Low rare disease awareness among physicians is believed to be one of the reasons for these late and misdiagnoses of rare disease patients. The aim of this study was to investigate how information and education could be tailored to the needs and preferences of physicians in Belgium to increase their rare disease awareness and support them in diagnosing patients with a rare disorder. Nine exploratory interviews with Belgian rare disease experts were performed in December 2016 to help the development of a questionnaire on information needs of physicians and their consulted information sources in rare disease awareness and diagnosis. This online questionnaire was then completed by Belgian physicians (n = 295), including general practitioners (GPs), pediatricians and other specialists (i.e. neurologists, pediatric neurologists, endocrinologists and pediatric endocrinologists) during January and February 2017.

Results

Rare disease knowledge and awareness were the lowest among GPs and the highest among specialists. Interviewed experts indicated that physicians’ academic and continuous medical education should be focused more on “red flags” to increase rare disease attentiveness in daily clinical practice. GPs scored their academic education on rare diseases as insufficient but pediatricians and other specialists scored it significantly better (p < 0.001). Even though GPs declared to only need information on rare diseases when having a rare disease patient in their practice, specialists indicated to need more rare disease information in general. Most physicians confirmed that they had specific information needs regarding rare diseases. Unlike specialists, the majority of GPs were unaware of information sources such as Orphanet.

Conclusion

In order to effectively support physicians in Belgium to diagnose rare diseases early, the academic medical education on rare diseases should be revised. Teaching methods should be focused more on casuistry and “red flags”. An Orphanet-like digital platform about rare disease symptoms, diagnostic tests and reference centers might be ideal to support correct and timely diagnosis.
Appendix
Available only for authorised users
Literature
1.
go back to reference De Sadeleer H. De zorg voor het kind door de huisarts en de pediater [dissertation]. Ghent: University of Ghent; 2016. De Sadeleer H. De zorg voor het kind door de huisarts en de pediater [dissertation]. Ghent: University of Ghent; 2016.
2.
go back to reference McIntyre FL. One in a million: when extraordinary cases occur in an ordinary practice. J Fam Pract. 1993;36(1):17–8.PubMed McIntyre FL. One in a million: when extraordinary cases occur in an ordinary practice. J Fam Pract. 1993;36(1):17–8.PubMed
4.
go back to reference Garcia-Ribes M, Ejarque I, Arenas E, Martin V. New challenges: general practitioners faced with “rare diseases”. Aten Primaria. 2006;37(7):369–70.CrossRefPubMed Garcia-Ribes M, Ejarque I, Arenas E, Martin V. New challenges: general practitioners faced with “rare diseases”. Aten Primaria. 2006;37(7):369–70.CrossRefPubMed
5.
go back to reference Kole A, Faurisson F, Mavris M. The voice of 12,000 patients. Experiences and expectations of rare disease patients on diagnosis and Care in Europe. Paris: EURORDIS; 2009. Kole A, Faurisson F, Mavris M. The voice of 12,000 patients. Experiences and expectations of rare disease patients on diagnosis and Care in Europe. Paris: EURORDIS; 2009.
6.
go back to reference Pfizer Inc. Training module transthyretin familial amyloid polyneuropathy (TTR-FAP) [for training purposes only. For internal use only.]. 2011. Pfizer Inc. Training module transthyretin familial amyloid polyneuropathy (TTR-FAP) [for training purposes only. For internal use only.]. 2011.
7.
go back to reference Engel P, Bagal A, Broback M, Boice N. Physician and patient perceptions regarding physician training in rare diseases: the need for stronger educational initiatives for physicians. J Rare Disord. 2013;1(2):1–15. Engel P, Bagal A, Broback M, Boice N. Physician and patient perceptions regarding physician training in rare diseases: the need for stronger educational initiatives for physicians. J Rare Disord. 2013;1(2):1–15.
8.
go back to reference Kharrazi M, Kharrazi LD. Delayed diagnosis of cystic fibrosis and the family perspective. J Pediatr. 2005;147(3 Suppl):S21–5.CrossRefPubMed Kharrazi M, Kharrazi LD. Delayed diagnosis of cystic fibrosis and the family perspective. J Pediatr. 2005;147(3 Suppl):S21–5.CrossRefPubMed
9.
go back to reference Adams D, Suhr OB, Hund E, Obici L, Tournev I, Campistol JM, et al. First European consensus for diagnosis, management, and treatment of transthyretin familial amyloid polyneuropathy. Curr Opin Neurol. 2016;29(Suppl 1):S14–26.CrossRefPubMedPubMedCentral Adams D, Suhr OB, Hund E, Obici L, Tournev I, Campistol JM, et al. First European consensus for diagnosis, management, and treatment of transthyretin familial amyloid polyneuropathy. Curr Opin Neurol. 2016;29(Suppl 1):S14–26.CrossRefPubMedPubMedCentral
10.
go back to reference ISEBOX Ltd/Shire. Rare disease impact report: insights from patients and the medical community 2013. ISEBOX Ltd/Shire. Rare disease impact report: insights from patients and the medical community 2013.
11.
go back to reference Muir E. Reality - an insight into the patient and family experience of rare disease. London: Rare Disease UK for Genetic Alliance UK; 2016. Muir E. Reality - an insight into the patient and family experience of rare disease. London: Rare Disease UK for Genetic Alliance UK; 2016.
13.
go back to reference Miteva T, Jordanova R, Iskrov G, Stefanov R. General knowledge and awareness on rare diseases among general practitioners in Bulgaria. Georgian Med News. 2011;(193):16–9. Miteva T, Jordanova R, Iskrov G, Stefanov R. General knowledge and awareness on rare diseases among general practitioners in Bulgaria. Georgian Med News. 2011;(193):16–9.
14.
go back to reference Bavisetty S, Grody WW, Yazdani S. Emergence of pediatric rare diseases: review of present policies and opportunities for improvement. Rare Dis (Austin, Tex). 2013;1:e23579. Bavisetty S, Grody WW, Yazdani S. Emergence of pediatric rare diseases: review of present policies and opportunities for improvement. Rare Dis (Austin, Tex). 2013;1:e23579.
15.
go back to reference Buntinx F, Mant D, Van den Bruel A, Donner-Banzhof N, Dinant GJ. Dealing with low-incidence serious diseases in general practice. Br J Gen Pract: the journal of the Royal College of General Practitioners. 2011;61(582):43–6.CrossRef Buntinx F, Mant D, Van den Bruel A, Donner-Banzhof N, Dinant GJ. Dealing with low-incidence serious diseases in general practice. Br J Gen Pract: the journal of the Royal College of General Practitioners. 2011;61(582):43–6.CrossRef
16.
go back to reference Taruscio D, Trama A, Stefanov R. Tackling rare diseases at European level: why do we need a harmonized framework? Folia Med. 2007;49(1–2):59–67. Taruscio D, Trama A, Stefanov R. Tackling rare diseases at European level: why do we need a harmonized framework? Folia Med. 2007;49(1–2):59–67.
17.
go back to reference Holtzman NA. Rare diseases, common problems: recognition and management. Pediatrics. 1978;62(6):1056–60.PubMed Holtzman NA. Rare diseases, common problems: recognition and management. Pediatrics. 1978;62(6):1056–60.PubMed
18.
go back to reference Gavhed D, Thorarinsson K, Lindbäck J, Larsson A, Henter JI. A survey about rare diseases among Swedish general practitioners [dissertation] [personal communication]. Stockholm: Karolinska Institutet, Karolinska University Hospital; 2012. Gavhed D, Thorarinsson K, Lindbäck J, Larsson A, Henter JI. A survey about rare diseases among Swedish general practitioners [dissertation] [personal communication]. Stockholm: Karolinska Institutet, Karolinska University Hospital; 2012.
19.
go back to reference Avellaneda Fernandez A, Perez Martin A, Pombo Alles G, Gutierrez Delgado E, Izquierdo Martinez M. Perception of rare diseases by the primary care physicians. Semergen / Sociedad Espanola de Medicina Rural y Generalista. 2012;38(7):421–31. Avellaneda Fernandez A, Perez Martin A, Pombo Alles G, Gutierrez Delgado E, Izquierdo Martinez M. Perception of rare diseases by the primary care physicians. Semergen / Sociedad Espanola de Medicina Rural y Generalista. 2012;38(7):421–31.
22.
go back to reference Dierckx de Casterle B, Gastmans C, Bryon E, Denier Y. QUAGOL: a guide for qualitative data analysis. Int J Nurs Stud. 2012;49(3):360–71.CrossRefPubMed Dierckx de Casterle B, Gastmans C, Bryon E, Denier Y. QUAGOL: a guide for qualitative data analysis. Int J Nurs Stud. 2012;49(3):360–71.CrossRefPubMed
23.
go back to reference Britten N. Qualitative Interviews. Qualitative Research in Health Care: Blackwell Publishing Ltd; 2007. p. 12–20. Britten N. Qualitative Interviews. Qualitative Research in Health Care: Blackwell Publishing Ltd; 2007. p. 12–20.
Metadata
Title
Information needs of physicians regarding the diagnosis of rare diseases: a questionnaire-based study in Belgium
Authors
Liese Vandeborne
Eline van Overbeeke
Marc Dooms
Birgit De Beleyr
Isabelle Huys
Publication date
01-12-2019
Publisher
BioMed Central
Published in
Orphanet Journal of Rare Diseases / Issue 1/2019
Electronic ISSN: 1750-1172
DOI
https://doi.org/10.1186/s13023-019-1075-8

Other articles of this Issue 1/2019

Orphanet Journal of Rare Diseases 1/2019 Go to the issue